You appear to be offline. Some data may be unavailable until your connection is restored.

ABT

Stock

Abbott Laboratories

Create price alert

Description

Abbott Laboratories is a global healthcare company that develops, manufactures and markets products across four main segments: medical devices, diagnostic systems, nutritional products and established pharmaceuticals, including branded generics. Its device portfolio features cardiovascular and electrophysiology technologies, structural‑heart and neuromodulation tools, while its diagnostics business offers laboratory and point‑of‑care testing platforms and the widely used FreeStyle Libre continuous glucose monitoring system. In nutrition, Abbott provides well‑known brands such as Similac infant formula and Ensure adult supplements, and its pharmaceutical segment focuses on affordable medicines in emerging markets. Operating in the broader healthcare sector, the company is recognized as a market leader in diabetes care, cardiovascular devices and diagnostic testing, with a diversified business model and a presence in more than 160 countries.

Quarterly Earnings

QuarterDateEPS
Q3 FY26Oct 15, 2026 (est.)
Q2 FY26Jul 16, 2026$1.31
Q1 FY26Apr 16, 2026$1.15
Q4 FY25Jan 22, 2026$1.50
Q3 FY25Oct 15, 2025$1.30

Stay ahead of ABT earnings

Get reminders ahead of ABT's next earnings report, so you always know when results are coming.